Dexcom will attend the Advanced Technologies and Treatments for Diabetes Conference in Barcelona on March 11-14, 2026, with event information at https://attd.kenes.com/. Dexcom is scheduled to host a symposium, “Dexcom technology, innovation and clinical implications: Current portfolio, near and long-term vision,” on Thursday, March 12, 2026 from 2:40-4:10 p.m. CET, in Auditorium. Dexcom is scheduled to host a symposium, “Transforming diabetes care: The power of Dexcom CGM from prediabetes to insulin therapy,” on Friday, March 13, 2026 from 8:30-9:20 a.m. CET, in Hall 113, Level P1. Dexcom will present an e-poster, “A reference framework for CGM training and education among healthcare providers,” on March 12, 2026 from 10:10-10:25 a.m. CET and on March 13, 2026 from 10:45-11:00 a.m. CET, at the Dexcom booth, 14A Level P0. Related materials referenced include full release, Dexcom Smart Basal, Dexcom G7 15 Day, and Dexcom Academy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexCom Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202603110200BIZWIRE_USPR_____20260310_BW854672) on March 11, 2026, and is solely responsible for the information contained therein.